Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AS1402 plus letrozole vs letrozole in first-line treatment of advanced/metastatic breast cancer
2008-001806-17Phase 2Active
- Sponsor
- Antisoma
- Start
- Jul 2008
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of bth1704 in breast cancer (2 arms), sponsored by Antisoma. Primary endpoint: Progression-free survival. Started Jul 2008; status: active.
02
Drugs
bth1704
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2008-001806-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-001806-17.